Cancer, Advanced Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02720068Study of MK-4280 as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy AND MK-4280A as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001)Treatment
NCT03568058Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced CancersTreatment
NCT03013218A Study of ALX148 in Patients With Advanced Solid Tumors and LymphomaTreatment